Agilent Technologies to Collaborate with Spain’s Centre for Omic Sciences
News Oct 31, 2012
The Centre for Omic Sciences, or COS, was established by the Rovira i Virgili University, in collaboration with the Technological Centre of Nutrition and Health. COS opened in September and is equipped with the latest instrumentation from Agilent, including the 6550 iFunnel Quadrupole Time-of-Flight LC/MS, 7200 Quadrupole Time-of-Flight GC/MS, 6490 iFunnel Triple Quadrupole LC/MS, Bravo automated liquid handling systems, and the SureScan DNA microarray scanner, software, consumables and services.
"Agilent is an ideal partner because many of their workflow solutions are an excellent fit for our approach to integrating data from different omics techniques,” said Oscar Yanes, principal investigator at the COS. “The ability to generate data using mostly Agilent instrumentation will facilitate the interpretation and integration of results from the different techniques.”
The COS will also serve as a center of excellence where Agilent will demonstrate integrated biology workflows to customers in such disciplines as genomics, proteomics, transcriptomics, lipidomics and metabolomics in search of biological breakthroughs.
"This is a very strategic association between two organizations with similar goals,” said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. “Both are committed to driving advances in medicine by developing better ways to integrate data from multiple biological disciplines. We share this vision.”
The COS will perform its collaborative research programs and services with the Technological Centre of Nutrition and Health and with private companies and research groups that take a special interest in the fields of diabetes and metabolic diseases, nutrition and health, and other biomedical research areas.
Researchers have performed the most definitive study to date on the relationship between technology use and adolescent mental health, examining data from over 300,000 teenagers and parents in the UK and USA. At most, only 0.4% of adolescent wellbeing is related to screen use - which only slightly surpasses the negative effect of regularly eating potatoes.
SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
May 15 - May 16, 2019